Home/Filings/4/0001615219-22-000019
4//SEC Filing

Rosenblum Mark J 4

Accession 0001615219-22-000019

CIK 0001615219other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:03 PM ET

Size

4.9 KB

Accession

0001615219-22-000019

Insider Transaction Report

Form 4
Period: 2022-03-03
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Purchase

    Common Stock

    2022-03-03$0.39/sh+76,246$29,812110,319 total
Footnotes (1)
  • [F1]The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001329154

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:03 PM ET
Size
4.9 KB